Abstract
Treatment with a combination of adriamycin (ADM) and cis-dichlorodiammineplatinum (II) (DDP) has been evaluated in 24 patients with advanced ovarian cancer. Twenty patients had received prior chemotherapy and/or radiation therapy. Objective remissions were seen in ten patients. The usual toxic manifestations of ADM and DDP were observed. It is concluded that the combination is effective therapy for ovarian cancer. Further investigation of this combination versus single agents is warranted.
| Original language | English |
|---|---|
| Pages (from-to) | 2027-2030 |
| Number of pages | 4 |
| Journal | Cancer Treatment Reports |
| Volume | 62 |
| Issue number | 12 |
| State | Published - 1978 |
| Externally published | Yes |